Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
156 hedge funds and large institutions have $167M invested in Spectrum Pharmaceuticals Inc in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 48 reducing their positions, and 35 closing their positions.
2% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 48
8% less funds holding
Funds holding: 169 → 156 (-13)
31% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 35
35% less call options, than puts
Call options by funds: $241K | Put options by funds: $369K
41% less capital invested
Capital invested by funds: $282M → $167M (-$114M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$7.41M |
| 2 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
+$1.87M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.86M |
| 4 |
Two Sigma Investments
New York
|
+$1.7M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$16.3M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$5.02M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.5M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$3.91M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.66M |
SPPI Hedge Fund Activity: Q1 2020 in Review
156 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2020, worth a combined $167M — down 41% from $282M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of SPPI and 24 opened new positions — a net loss of 11 holders — while 48 trimmed existing stakes and 47 added.
The largest buyer was Morgan Stanley, adding an estimated $7.41M. The largest seller was Primecap Management, cutting an estimated $16.3M.
- 156 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2020, down from 169 in Q4 2019.
- Funds reported $167M of Spectrum Pharmaceuticals Inc stock for Q1 2020, down 41% quarter-over-quarter.
- 24 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2020 and 35 closed out, a net change of -11 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q1 2020 was Morgan Stanley, an estimated $7.41M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q1 2020 was Primecap Management, an estimated $16.3M sold.
Based on aggregated 13F filings for Q1 2020.